Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Molecular basis for polycythemia.

J F Prchal1, J T Prchal

  • 1Division of Hematology/Oncology, University of Alabama at Birmingham, 35294, USA.

Current Opinion in Hematology
|March 24, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Adaptive genetic changes related to haemoglobin concentration in native high-altitude Tibetans.

Experimental physiology·2015
Same author

Presence of polyclonal hematopoiesis in females with Ph-negative myeloproliferative neoplasms.

Leukemia·2015
Same author

End-tidal carbon monoxide as an indicator of the hemolytic rate.

Blood cells, molecules & diseases·2015
Same author

The relationship of JAK2(V617F) and acquired UPD at chromosome 9p in polycythemia vera.

Leukemia·2014
Same author

Whole-exome sequencing of polycythemia vera revealed novel driver genes and somatic mutation shared by T cells and granulocytes.

Leukemia·2014
Same author

Establishing optimal quantitative-polymerase chain reaction assays for routine diagnosis and tracking of minimal residual disease in JAK2-V617F-associated myeloproliferative neoplasms: a joint European LeukemiaNet/MPN&MPNr-EuroNet (COST action BM0902) study.

Leukemia·2013
Same journal

Dynamic myeloid suppressor states in cancer and inflammation and their therapeutic potential.

Current opinion in hematology·2026
Same journal

Factor XIa inhibition for the prevention of thrombosis: mechanism, clinical trial signals, and indication-specific positioning.

Current opinion in hematology·2026
Same journal

Nutrition as a regulator of hematopoietic stem cell biology and transplantation.

Current opinion in hematology·2026
Same journal

From biomimicry to clinical actionability: rethinking high-shear thrombosis as a mechanobiological system.

Current opinion in hematology·2026
Same journal

Bidirectional relationship between metabolic and thrombotic disease mechanisms.

Current opinion in hematology·2026
Same journal

The dual role of the brain-derived neurotrophic factor as a regulator of hemostasis and thrombotic risk.

Current opinion in hematology·2026
See all related articles

This overview covers familial and congenital polycythemias, focusing on genetic causes and molecular defects. It explores erythropoiesis regulation and specific polycythemic disorders like polycythemia vera and Chuvash polycythemia.

Area of Science:

  • Hematology
  • Genetics
  • Molecular Biology

Background:

  • Polycythemia, a condition of elevated red blood cells, can be inherited or congenital.
  • Understanding erythropoiesis regulation is key to polycythemic states.
  • Established molecular lesions are central to diagnosing familial and congenital polycythemias.

Purpose of the Study:

  • To provide an overview of familial and congenital polycythemias.
  • To discuss recent advances in erythropoiesis regulation relevant to polycythemia.
  • To highlight polycythemic states with known and unknown molecular defects.

Main Methods:

  • Literature review and synthesis of current research.
  • Discussion of molecular lesions in various polycythemic disorders.

Related Experiment Videos

  • Analysis of erythropoiesis regulation mechanisms.

    • Main Results:

    • Detailed discussion of primary familial congenital polycythemias.
    • Exploration of congenital and familial secondary polycythemias, including hemoglobin mutants, methemoglobinemias, and 2,3-bisphosphoglycerate deficiency.
    • Focus on polycythemia vera and Chuvash polycythemia as key examples.

    Conclusions:

    • Familial and congenital polycythemias are diverse disorders with specific molecular underpinnings.
    • Further research into erythropoiesis regulation can elucidate mechanisms in undefined polycythemic states.
    • Polycythemia vera and Chuvash polycythemia represent common and endemic forms, respectively.